Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. It can affect arteries, veins, and capillaries. This condition causes blood vessel walls to swell, which restricts ...

less than 5% plasma cells in bone marrow, normal free light-chain ratio, and absence of clonal cells in bone marrow on immunohistochemical or immunofluorescence analysis) and minimal residual ...

Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life benefit and no new safety signals with multiple years of ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...

Shorla currently markets two products, Nelarabine for the treatment of T-cell leukemia and JYLAMVO for ... monitor patients regularly for signs and symptoms of fluid retention.

Many people with other plasma cell diseases like MGUS or solitary plasmacytoma will eventually develop multiple myeloma. Common symptoms of multiple myeloma ... the possibility of cure for myeloma and ...

Vaccine effectiveness relies on creating a strong antibody response that can be reactivated to fight future infections. Now, ...

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...

which aims to destroy leukemia cells in the bone marrow and blood to put AML into remission. Remission means that signs and symptoms of cancer have decreased or gone away. Post-remission therapy ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer.